HomepageNBIX • NASDAQ
add
Neurocrine Biosciences
Vorige slotkoers
$ 138,71
Dag-range
$ 137,49 - $ 142,83
Jaar-range
$ 110,95 - $ 157,98
Beurswaarde
14,27 mld. USD
Gem. volume
938,82K
Koers/winst
37,73
Dividendrendement
-
Primaire beurs
NASDAQ
Marktnieuws
Financiële informatie
Resultatenrekening
Opbrengst
Netto inkomsten
(USD) | sep 2024info | Wijziging j-o-j |
---|---|---|
Opbrengst | 622,10 mln. | 24,72% |
Bedrijfskosten | 234,30 mln. | 14,74% |
Netto inkomsten | 129,80 mln. | 56,20% |
Netto winstmarge | 20,86 | 25,21% |
Winst per aandeel | 1,81 | 17,53% |
EBITDA | 191,30 mln. | 30,40% |
Effectief belastingtarief | 31,79% | — |
Balans
Totale activa
Totale passiva
(USD) | sep 2024info | Wijziging j-o-j |
---|---|---|
Contanten en kortetermijnbeleggingen | 1,23 mld. | 12,14% |
Totale activa | 3,54 mld. | 24,11% |
Totale passiva | 816,10 mln. | -3,55% |
Totaal aandelenvermogen | 2,72 mld. | — |
Uitstaande aandelen | 101,25 mln. | — |
Koers-boekwaardeverhouding | 5,16 | — |
Rendement op activa | 13,51% | — |
Rendement op kapitaal | 15,91% | — |
Kasstroom
Nettomutatie in liquide middelen
(USD) | sep 2024info | Wijziging j-o-j |
---|---|---|
Netto inkomsten | 129,80 mln. | 56,20% |
Operationele kasstroom | 158,00 mln. | -25,47% |
Kasstroom uit beleggingen | 24,70 mln. | 125,39% |
Kasstroom uit financiering | 26,40 mln. | 40,43% |
Nettomutatie in liquide middelen | 209,40 mln. | 56,85% |
Vrije kasstroom | -10,40 mln. | -106,50% |
Over
Neurocrine Biosciences, Inc. is an American biopharmaceutical company founded in 1992. It is headquartered in San Diego, California, and led by CEO Kevin Gorman. Neurocrine develops treatments for neurological and endocrine-related diseases and disorders. In 2017, the company's drug valbenazine was approved in the US to treat adults with tardive dyskinesia.
The company is also developing treatments that are in various stages of clinical research for Parkinson's disease, Tourette syndrome, and congenital adrenal hyperplasia and with a partner for endometriosis and uterine fibroids. Wikipedia
Opgericht
1992
Hoofdvestiging
Website
Werknemers
1.700